3 min read

UBC Enhances In-Workflow for Patient Support Program Enrollment

UBC announces enhanced in-workflow capabilities for healthcare practitioners.

The in-workflow service starts when a prescriber sends a prescription to the UBC Pharmacy. From there, UBC Pathways technology, a suite of solutions to help patients access and adhere to therapy, enables case managers to provide a robust range of services. Integrating this technology simplifies therapy initiation and allows for a more efficient path to services such as eligibility and coverage determination, prior authorization, appeal, affordability, patient engagement, adherence, as well as ongoing care coordination with other fulfillment pharmacies and distributors.

Ron Lacy, Vice President Product and Innovation, UBC said, “the therapies our clients are launching into the market demand the most seamless onboarding experience that combines leading technologies, comprehensive patient access services, and highly skilled clinical staff to optimize how patients start and stay on therapy long-term. UBC expanded the UBC Pharmacy technology platform to facilitate access to the network of UBC-partner pharmacies. This includes a wide mix of both leading commercial specialty pharmacies, retail and non-commercial pharmacies.”

Lacy continued, “Our clients value the flexibility to add their own preferred specialty pharmacies to the network or utilize any or all of the existing UBC network partners. UBC leverages a shared common pharmacy transfer platform enabling wider distribution and coverage options for patients.”

UBC is committed to improving experiences and outcomes through access, education, and care coordination for patients on specialty products. This commitment includes the organization’s innovative UBC Pathways Platform providing a range of services, including electronic enrollment, electronic benefit verification (eBV), electronic prior authorization (ePA), and the latest mobile messaging solution, UBC Pathways Engage.

About UBC
United BioSource LLC (UBC) is a leader in the biopharmaceutical market which provides integrated clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. Comprehensive, end-to-end services cover product and patient population characterization during development and market entry, as well as a focus on the patient experience, safety, and adherence.

Other Recent Posts

3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
3 min read

UBC Recognized as a Citeline Awards Finalist Again

The Citeline Awards have recognized UBC & Seqster’s innovative collaboration as a shortlisted finalist for the Best Patient-Facing Technology Initiative Category in 2023.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.